Lazard Capital Starts Gen-Probe (GPRO) at Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/20/2026
- Dow leads Wall Street higher, investors focus on healthcare stocks
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Loop Capital downgrades Apple, sees no recovery of cut iPhone shipments
- Wells Fargo says S&P 500 buy signal emerges as investors turn excessively bearish
- ByteDance, Alibaba and Tencent order $35 billion of Nvidia chips: Reuters
Tweet
Share
E-mailGet Alerts GPRO Hot Sheet
Price: $1.10 +5.77%
Rating Summary:
4 Buy, 11 Hold, 6 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 26 | New: 32
Rating Summary:
4 Buy, 11 Hold, 6 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 26 | New: 32
Join SI Premium – FREE
Lazard Capital initiates coverage on Gen-Probe (NASDAQ: GPRO) with a Neutral.
For more ratings news on Gen-Probe click here and for the rating history of Gen-Probe click here.
Shares of Gen-Probe closed at $57.38 yesterday.
For more ratings news on Gen-Probe click here and for the rating history of Gen-Probe click here.
Shares of Gen-Probe closed at $57.38 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Texas Capital Securities Starts NioCorp Developments Ltd. (NB) at Buy, PT $13
- Evercore ISI Starts Kestra Medical Technologies (KMTS) at Outperform
- GoPro files merger proxy, restates financials over warrant accounting errors
Create E-mail Alert Related Categories
New CoverageRelated Entities
LazardSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
